Assessment of Nutritional Status and Role of Insulin-like Growth Factor-1 in Children

Assessment of Nutritional Status and Role of Insulin-like Growth Factor-1 in Children With Thalassemia Major

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05529550

Enrollment

102

Registered

2022-09-07

Start date

2020-10-01

Completion date

2021-12-01

Last updated

2022-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thalassemia

Keywords

Insulin-like growth factor 1

Brief summary

Many studies done on children with thalassemia have shown a variable prevalence of defective IGF-I concentrations have been shown to be low in the majority of children, with or without GH deficiency. The Aim of this study to assess nutritional status and role of Insulin-like growth factor 1 (IGF-1) and its associating factors in children with thalassemia major

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

1 Years to 18 Years

Inclusion criteria

* Children in the age group of 2-18 years with confirmed diagnosis of Beta thalassemia major.

Exclusion criteria

* Children with other chronic diseases (cardiac, renal, vascular) * Children with malignancy

Design outcomes

Primary

Measure	Time frame	Description
IGF-1	at the time of recruitment	insulin-like growth factor-1 which measured by enzyme linked immunosorbent assay (ELISA).

Countries

Egypt

Outcome results